<DOC>
	<DOC>NCT00660998</DOC>
	<brief_summary>Asses efficacy of Vardenafil in patients with type 1 diabetes and erectile dysfunction</brief_summary>
	<brief_title>Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Men &gt;/= 18 years of age, with 6 months or longer diagnosis of ED as defined by NIH Consensus statement, Diabetes type 1 Stable sexual relationship for &gt; 6 month. Primary hypoactive sexual desire History of myocardial infarction, stroke or lifethreatening arrhythmia within prior 6 month Nitrate therapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Diabetes mellitus type 1</keyword>
	<keyword>Vardenafil</keyword>
</DOC>